Interest in xenotransplantation derives from the documented need for more o
rgans and tissues than can be expected from living or cadaveric donors, Alt
hough the barriers to xenotransplantation are formidable, the scientific re
wards in addressing these problems have been significant. The first and mos
t potent barrier to xenotransplantation is hyperacute rejection mediated by
xenoreactive natural antibodies and serum complement. The majority of the
xenoreactive antibodies appear to be directed at terminal galactose epitope
s, especially gal alpha1-3 gal. Significant progress has been made in surmo
unting hyperacute rejection, and this has led to an examination of underlyi
ng mechanisms of delayed xenograft rejection. One of these delayed mechanis
ms concerns the potential role of graft recipient, natural killer (NK) cell
s, NK cells can cause variable, low-level cytotoxicity of xenogeneic endoth
elial cells in vitro that may be enhanced in the presence of xenoreactive I
gG. The specificity of NK cell-mediated cytotoxicity appears to overlap wit
h a major subset of xenoreactive natural antibodies. These cytotoxic intera
ctions can be regulated by "humanizing" the endothelial cells through expre
ssion of the appropriate human MHC class I genes. More important, NK cells
induce endothelial cell activation, which results in changing the nature of
the endothelial cell surface from an anticoagulant surface to a procoagula
nt surface. These findings parallel those observed in allogeneic NK cell-en
dothelial cell interactions and suggest these important observations may be
extended to NK cell endothelial cell interactions in general.